Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Alzheimer’s Drug

Eli Lilly & Co. sued the University of California, San Diego, in Superior Court, claiming that UCSD diverted nearly $20 million of the $38 million that it provided for a clinical study of solanezumab, an Alzheimer’s drug.

SAN DIEGO — Eli Lilly & Co. sued the University of California, San Diego, in Superior Court, claiming that UCSD diverted nearly $20 million of the $38 million that it provided for a clinical study of solanezumab, an Alzheimer’s drug.

Categories / Education, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...